# Mangoceuticals Inc. (MGRX)

Source: https://www.quantisnow.com/company/MGRX
Generated: 2026-11-19T16:10:04.529Z

- Ticker: MGRX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Misc Health and Biotechnology Services
- IPO year: 2023
- SEC CIK: 0001938046

## Latest MGRX news and filings

- 2026-11-17 22:25 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-mangoceuticals-inc-6797389)
- 2026-11-13 22:25 UTC [SEC Form 8-K] [Mangoceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mangoceuticals-inc-filed-sec-form-8-k-material-modification-to-rights-6791504)
- 2026-11-12 12:00 UTC [SEC Form 1-A filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-1-a-filed-by-mangoceuticals-inc-6786074)
- 2026-11-12 12:00 UTC [Dividends] [Mangoceuticals Partners with T7X to Become the First Nasdaq-Listed Company to Offer Tokenized Preferred Stock on the T7X Platform](https://www.quantisnow.com/insight/mangoceuticals-partners-with-t7x-to-become-the-first-nasdaq-listed-company-6786000)
- 2026-11-06 22:25 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-mangoceuticals-inc-6779574)
- 2026-11-06 22:25 UTC [SEC Form 8-K] [Mangoceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Shareholder Director Nominations, Other Events](https://www.quantisnow.com/insight/mangoceuticals-inc-filed-sec-form-8-k-submission-of-matters-to-6779572)
- 2026-10-09 20:01 UTC [SEC Form 8-K] [SEC Form 8-K filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-mangoceuticals-inc-6742808)
- 2026-10-09 20:00 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-mangoceuticals-inc-6742785)
- 2026-10-09 20:01 UTC [Public Offering] [Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close](https://www.quantisnow.com/insight/mangoceuticals-closes-registered-direct-offering-priced-at-74-premium-to-6742778)
- 2026-10-06 12:00 UTC [SEC Form 4] [SEC Form 4 filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-mangoceuticals-inc-6738245)
- 2026-10-06 12:00 UTC [SEC Form 4] [SEC Form 4 filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-mangoceuticals-inc-6738243)
- 2026-10-06 12:00 UTC [SEC Form 4] [SEC Form 4 filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-mangoceuticals-inc-6738240)
- 2026-10-06 12:00 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-mangoceuticals-inc-6738239)
- 2026-10-01 19:50 UTC [SEC Form 8-K] [Mangoceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Regulation FD Disclosure](https://www.quantisnow.com/insight/mangoceuticals-inc-filed-sec-form-8-k-entry-into-a-material-6732265)
- 2026-08-21 21:15 UTC [SEC Form 8-K] [Mangoceuticals Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mangoceuticals-inc-filed-sec-form-8-k-termination-of-a-material-6691694)
- 2026-08-13 21:27 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-mangoceuticals-inc-6681346)
- 2026-08-13 20:21 UTC [SEC Form 425] [SEC Form 425 filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-mangoceuticals-inc-6680752)
- 2026-08-13 20:05 UTC [Nuclea Energy, Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets](https://www.quantisnow.com/insight/nuclea-energy-enters-into-definitive-agreement-to-acquire-moltex-energys-6680257)
- 2026-08-13 20:05 UTC [Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets](https://www.quantisnow.com/insight/mangoceuticals-incs-merger-partner-nuclea-energy-inc-enters-into-definitive-6680215)
- 2026-08-06 11:00 UTC [Nuclea Energy Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure](https://www.quantisnow.com/insight/nuclea-energy-signs-mou-with-new-mining-co-to-advance-6667155)
- 2026-08-06 11:00 UTC [Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure](https://www.quantisnow.com/insight/mangoceuticals-merger-partner-nuclea-energy-inc-signs-mou-with-new-6667075)
- 2026-08-05 20:05 UTC [Nuclea Energy USA Inc. Announces MOU with Utah Office of Energy Development](https://www.quantisnow.com/insight/nuclea-energy-usa-inc-announces-mou-with-utah-office-of-6665027)
- 2026-08-05 20:05 UTC [Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development](https://www.quantisnow.com/insight/mangoceuticals-merger-partner-nuclea-energy-nuclea-executes-mou-with-utah-6664910)
- 2026-08-04 20:30 UTC [SEC Form 425] [SEC Form 425 filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-mangoceuticals-inc-6662595)
- 2026-08-04 20:05 UTC [SEC Form 8-K] [Mangoceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mangoceuticals-inc-filed-sec-form-8-k-other-events-financial-statements-6662087)
- 2026-08-04 20:05 UTC [Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination](https://www.quantisnow.com/insight/mangoceuticals-granted-180-day-extension-by-nasdaq-to-regain-compliance-with-6661968)
- 2026-07-30 21:23 UTC [SEC Form 425] [SEC Form 425 filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-mangoceuticals-inc-6656649)
- 2026-07-30 14:35 UTC [Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor](https://www.quantisnow.com/insight/nuclea-energy-enters-definitive-business-combination-agreement-with-mangoceuticals-establishing-6655457)
- 2026-07-30 11:01 UTC [SEC Form 425] [SEC Form 425 filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-mangoceuticals-inc-6654903)
- 2026-07-30 11:00 UTC [SEC Form 8-K] [Mangoceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mangoceuticals-inc-filed-sec-form-8-k-entry-into-a-material-6654896)
- 2026-07-30 11:00 UTC [Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology](https://www.quantisnow.com/insight/mangoceuticals-announces-business-combination-agreement-with-nuclea-energy-inc-to-6654828)
- 2026-07-10 21:15 UTC [SEC Form S-8] [SEC Form S-8 filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-mangoceuticals-inc-6634425)
- 2026-07-02 20:30 UTC [SEC Form 8-K] [Mangoceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mangoceuticals-inc-filed-sec-form-8-k-entry-into-a-material-6625792)
- 2026-05-19 20:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-mangoceuticals-inc-6562974)
- 2026-05-15 20:40 UTC [SEC Form NT 10-Q filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-mangoceuticals-inc-6558025)
- 2026-04-01 10:31 UTC [SEC Form 10-K] [SEC Form 10-K filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-mangoceuticals-inc-6480561)
- 2026-03-31 21:25 UTC [SEC Form NT 10-K filed by Mangoceuticals Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-mangoceuticals-inc-6480034)
- 2026-03-20 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Cohen Jacob D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-cohen-jacob-d-6463618)
- 2026-03-20 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Cohen Jacob D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-cohen-jacob-d-6463617)
- 2026-03-17 20:00 UTC [SEC Form 8-K] [Mangoceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/mangoceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-financial-6452191)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MGRX
- Earnings history: https://www.quantisnow.com/earnings/MGRX
- Dividend history: https://www.quantisnow.com/dividends/MGRX
- Insider transactions: https://www.quantisnow.com/insiders/MGRX
- Options chain: https://www.quantisnow.com/options/MGRX
- SEC 8-K filings only: https://www.quantisnow.com/company/MGRX/8-k
- RSS and alerts for MGRX: https://www.quantisnow.com/docs/rss-feeds.md
